Verastem, Inc. (VSTM)
8.41
-0.97
(-10.34%)
USD |
NASDAQ |
Nov 06, 16:00
8.31
-0.10
(-1.19%)
After-Hours: 20:00
Verastem Total Long Term Debt (Quarterly) : 127.79M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 127.79M |
| June 30, 2026 | 83.62M |
| March 31, 2026 | 84.45M |
| December 31, 2025 | 86.63M |
| September 30, 2025 | 88.50M |
| June 30, 2025 | 83.20M |
| March 31, 2025 | 75.04M |
| December 31, 2024 | 41.26M |
| September 30, 2024 | 40.52M |
| June 30, 2024 | 40.32M |
| March 31, 2024 | 50.59M |
| December 31, 2023 | 40.62M |
| September 30, 2023 | 48.39M |
| June 30, 2023 | 49.09M |
| March 31, 2023 | 45.62M |
| December 31, 2022 | 26.27M |
| September 30, 2022 | 26.35M |
| June 30, 2022 | 26.42M |
| March 31, 2022 | 26.49M |
| December 31, 2021 | 2.513M |
| September 30, 2021 | 2.686M |
| June 30, 2021 | 22.94M |
| March 31, 2021 | 22.45M |
| December 31, 2020 | 21.98M |
| September 30, 2020 | 59.62M |
| Date | Value |
|---|---|
| June 30, 2020 | 59.09M |
| March 31, 2020 | 58.57M |
| December 31, 2019 | 107.11M |
| September 30, 2019 | 139.70M |
| June 30, 2019 | 137.53M |
| March 31, 2019 | 125.78M |
| December 31, 2018 | 120.45M |
| September 30, 2018 | 25.06M |
| June 30, 2018 | 24.90M |
| March 31, 2018 | 14.91M |
| December 31, 2017 | 14.83M |
| September 30, 2017 | 2.335M |
| June 30, 2017 | 2.293M |
| March 31, 2017 | 2.249M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Cytokinetics, Inc. | 1.251B |
| Inovio Pharmaceuticals, Inc. | 5.103M |
| Rigel Pharmaceuticals, Inc. | 7.236M |
| United Therapeutics Corp. | 0.00 |
| SELLAS Life Sciences Group, Inc. | 0.157M |